Search

Your search keyword '"Kuroi, Taiga"' showing total 26 results
Start Over Author "Kuroi, Taiga"
26 results on '"Kuroi, Taiga"'

2. A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan

Author

Horigome, Yuichi, Iino, Masaki, Harazaki, Yoriko, Kobayashi, Takahiro, Handa, Hiroshi, Hiramatsu, Yasushi, Kuroi, Taiga, Tanimoto, Kazuki, Matsue, Kosei, Abe, Masahiro, Ishida, Tadao, Ito, Shigeki, Iwasaki, Hiromi, Kuroda, Junya, Shibayama, Hirohiko, Sunami, Kazutaka, Takamatsu, Hiroyuki, Tamura, Hideto, Hayashi, Toshiaki, Akagi, Kiwamu, Maeda, Takahiro, Yoshida, Takahiro, Mori, Ikuo, Shinozaki, Tomohiro, and Iida, Shinsuke

Published
2024
Full Text
View/download PDF

4. An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)

Author

Abe, Yu, primary, Kubonishi, Shiro, additional, Ri, Masaki, additional, Iino, Masaki, additional, Sunami, Kazutaka, additional, Ito, Tomoki, additional, Fukaya, Masafumi, additional, Kitano, Toshiyuki, additional, Ikeda, Sho, additional, Ota, Shuichi, additional, Kuroi, Taiga, additional, Iriyama, Noriyoshi, additional, Jo, Tatsuro, additional, Adachi, Masaaki, additional, Akahane, Daigo, additional, Kai, Tatsuyuki, additional, Kohara, Yoichi, additional, Kadowaki, Norimitsu, additional, and Katayama, Teruaki, additional

Published
2024
Full Text
View/download PDF

6. A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan

Author

Horigome, Yuichi, primary, Iino, Masaki, additional, Harazaki, Yoriko, additional, Kobayashi, Takahiro, additional, Handa, Hiroshi, additional, Hiramatsu, Yasushi, additional, Kuroi, Taiga, additional, Tanimoto, Kazuki, additional, Matsue, Kosei, additional, Abe, Masahiro, additional, Ishida, Tadao, additional, Ito, Shigeki, additional, Iwasaki, Hiromi, additional, Kuroda, Junya, additional, Shibayama, Hirohiko, additional, Sunami, Kazutaka, additional, Takamatsu, Hiroyuki, additional, Tamura, Hideto, additional, Hayashi, Toshiaki, additional, Akagi, Kiwamu, additional, Maeda, Takahiro, additional, Yoshida, Takahiro, additional, Mori, Ikuo, additional, Shinozaki, Tomohiro, additional, and Iida, Shinsuke, additional

Published
2023
Full Text
View/download PDF

9. Prevention of non-infectious pulmonary complications after intra-bone marrow stem cell transplantation in mice

Author

Yamasuji-Maeda, Yoshiko, primary, Nishimori, Hisakazu, additional, Seike, Keisuke, additional, Yamamoto, Akira, additional, Fujiwara, Hideaki, additional, Kuroi, Taiga, additional, Saeki, Kyosuke, additional, Fujinaga, Haruko, additional, Okamoto, Sachiyo, additional, Matsuoka, Ken-ichi, additional, Fujii, Nobuharu, additional, Tanaka, Takehiro, additional, Fujii, Masahiro, additional, Mominoki, Katsumi, additional, Kanekura, Takuro, additional, and Maeda, Yoshinobu, additional

Published
2022
Full Text
View/download PDF

10. P-248: A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in 295 Japanese patients with relapsed/refractory multiple myeloma

Author

Iino, Masaki, primary, Horigome, Yuichi, additional, Harazaki, Yoriko, additional, Kobayashi, Takahiro, additional, Handa, Hiroshi, additional, Hiramatsu, Yasushi, additional, Kuroi, Taiga, additional, Tanimoto, Kazuki, additional, Matsue, Kosei, additional, Yoshida, Takahiro, additional, Mori, Ikuo, additional, Abe, Masahiro, additional, Akagi, Kiwamu, additional, Hayashi, Toshiaki, additional, Ishida, Tadao, additional, Ito, Shigeki, additional, Iwasaki, Hiromi, additional, Kuroda, Junya, additional, Maeda, Takahiro, additional, Shibayama, Hirohiko, additional, Sunami, Kazutaka, additional, Takamatsu, Hiroyuki, additional, Tamura, Hideto, additional, Shinozaki, Tomohiro, additional, and Iida, Shinsuke, additional

Published
2022
Full Text
View/download PDF

11. Prevention of non-infectious pulmonary complications after intra-bone marrow stem cell transplantation in mice

Author

Yamasuji-Maeda, Yoshiko, Nishimori, Hisakazu, Seike, Keisuke, Yamamoto, Akira, Fujiwara, Hideaki, Kuroi, Taiga, Saeki, Kyosuke, Fujinaga, Haruko, Okamoto, Sachiyo, Matsuoka, Ken-Ichi, Fujii, Nobuharu, Tanaka, Takehiro, Fujii, Masahiro, Mominoki, Katsumi, Kanekura, Takuro, Maeda, Yoshinobu, Yamasuji-Maeda, Yoshiko, Nishimori, Hisakazu, Seike, Keisuke, Yamamoto, Akira, Fujiwara, Hideaki, Kuroi, Taiga, Saeki, Kyosuke, Fujinaga, Haruko, Okamoto, Sachiyo, Matsuoka, Ken-Ichi, Fujii, Nobuharu, Tanaka, Takehiro, Fujii, Masahiro, Mominoki, Katsumi, Kanekura, Takuro, and Maeda, Yoshinobu

Abstract

Non-infectious pulmonary complications including idiopathic pneumonia syndrome (IPS) and bronchiolitis obliterans syndrome (BOS), which are clinical and diagnostic manifestations of lung chronic graft-versus-host disease (GVHD), cause significant mortality after allogeneic stem cell transplantation (SCT). Increasing evidence suggests that alloantigen reactions in lung tissue play a central role in the pathogenesis of IPS and BOS; however, the mechanism is not fully understood. Several clinical and experimental studies have reported that intrabone marrow (IBM)-SCT provides high rates of engraftment and is associated with a low incidence of acute GVHD. In the present study, allogeneic SCT was conducted in mouse models of IPS and BOS, to compare intravenous (IV)-SCT with IBM-SCT. Allogeneic IBM-SCT improved the clinical and pathological outcomes of pulmonary complications compared to those of IV-SCT. The mechanisms underlying the reductions in pulmonary complications in IBM-SCT mice were explored. The infiltrating lung cells were mainly CD11b+ myeloid and CD3+ T cells, in the same proportions as in transplanted donor cells. In an in vivo bioluminescence imaging, a higher proportion of injected donor cells was detected in the lung during the early phase (1 h after IV-SCT) than after IBM-SCT (16.7 +/- 1.1 vs. 3.1 +/- 0.7 x 10(5) photons/s/animal, IV-SCT vs. IBM-SCT, P = 1.90 x 10(-10)). In the late phase (5 days) after SCT, there were also significantly more donor cells in the lung after IV-SCT than after IBM-SCT or allogeneic-SCT (508.5 +/- 66.1 vs. 160.1 +/- 61.9 x 10(6) photons/s/animal, IV-SCT vs. IBM-SCT, P = 0.001), suggesting that the allogeneic reaction induces sustained donor cell infiltration in the lung during the late phase. These results demonstrated that IBM-SCT is capable of reducing injected donor cells in the lung; IBM-SCT decreases donor cell infiltration. IBM-SCT therefore represents a promising transplantation strategy for reducing pulmonary complicat

Published
2022

14. Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy

Author

Kiso, Sayaka, primary, Sugiura, Hiroyuki, additional, Kuroi, Taiga, additional, Omote, Rika, additional, Toji, Tomohiro, additional, Ishikawa, Tatsunori, additional, Okamoto, Sachiyo, additional, Nomura, Naho, additional, Masunari, Taro, additional, Sezaki, Nobuo, additional, Kiguchi, Toru, additional, and Tanimoto, Mitsune, additional

Published
2021
Full Text
View/download PDF

15. Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome

Author

Sugiura, Hiroyuki, primary, Matsuoka, Ken-ichi, additional, Matsuda, Masayuki, additional, Ikegawa, Shuntaro, additional, Inomata, Tomoko, additional, Kuroi, Taiga, additional, Asano, Takeru, additional, Yoshida, Shohei, additional, Nishimori, Hisakazu, additional, Fujii, Keiko, additional, Fujii, Nobuharu, additional, and Maeda, Yoshinobu, additional

Published
2019
Full Text
View/download PDF

20. Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia

Author

Asano, Takeru, primary, Ikegawa, Shuntaro, additional, Inomata, Tomoko, additional, Ikeda, Naoto, additional, Sugiura, Hiroyuki, additional, Kuroi, Taiga, additional, Yoshida, Shohei, additional, Nishimori, Hisakazu, additional, Matsuoka, Ken-ichi, additional, Fujii, Nobuharu, additional, Kondo, Eisei, additional, Maeda, Yoshinobu, additional, and Tanimoto, Mitsune, additional

Published
2016
Full Text
View/download PDF

21. Successful Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mild Renal Dysfunction Calculated By Creatinin Clearance

Author

Ikegawa, Shuntaro, primary, Inomata, Tomoko, additional, Ikeda, Naoto, additional, Sugiura, Hiroyuki, additional, Kuroi, Taiga, additional, Asano, Takeru, additional, Yoshida, Shohei, additional, Nishimori, Hisakazu, additional, Matsuoka, Ken-ichi, additional, Fujii, Nobuharu, additional, Kondo, Eisei, additional, Maeda, Yoshinobu, additional, and Tanimoto, Mitsune, additional

Published
2016
Full Text
View/download PDF

23. Anti-IL-12/23 p40 Antibody Attenuates Chronic Graft Versus Host Disease Via Suppression of IFN-γ/IL-17-Producing Cells

Author

Kuroi, Taiga, primary, Okamoto, Sachiyo, additional, Saeki, Kyosuke, additional, Kobayashi, Yujin, additional, Nishimori, Hisakazu, additional, Fujiwara, Hideaki, additional, Matsuoka, Ken-ichi, additional, Fujii, Nobuharu, additional, Kondo, Eisei, additional, Tanimoto, Mitsune, additional, and Maeda, Yoshinobu, additional

Published
2014
Full Text
View/download PDF

24. Gastrointestinal hemorrhage caused by the direct invasion of a hepatocellular carcinoma successfully treated with polyglycolic acid sheet shielding.

Author

Tomohiko Mannami, Nobukiyo Fujiwara, Genyo Ikeda, Takahito Mishima, Taiga Kuroi, Takayuki Muraoka, Yasuyuki Ohtawa, Mannami, Tomohiko, Fujiwara, Nobukiyo, Ikeda, Genyo, Mishima, Takahito, Kuroi, Taiga, Muraoka, Takayuki, and Ohtawa, Yasuyuki

Subjects
LIVER cancer, CIRRHOSIS of the liver
Abstract

The article presents a case study of a 76-year-old man with a history of alcohol liver cirrhosis who have been previously diagnosed with hepatocellular carcinoma.

Published
2019
Full Text
View/download PDF

25. Sigle Agent of Posttransplant Cyclophosphamide Without Calcineurin Inhibitor Controls Severity of Experimental Chronic GVHD.

Author

Saeki K, Fujiwara H, Seike K, Kuroi T, Nishimori H, Tanaka T, Matsuoka KI, Fujii N, and Maeda Y

Subjects
Animals, Mice, Chronic Disease, Immunosuppressive Agents therapeutic use, Calcineurin Inhibitors therapeutic use, Female, Mice, Inbred BALB C, Mice, Inbred C57BL, Cyclosporine therapeutic use, Disease Models, Animal, Graft vs Host Disease prevention & control, Graft vs Host Disease drug therapy, Cyclophosphamide therapeutic use, Cyclophosphamide administration & dosage, Hematopoietic Stem Cell Transplantation adverse effects
Abstract

Chronic graft-versus-host disease (GVHD) is a major cause of late death and morbidity following allogeneic hematopoietic cell transplantation (HCT), but its pathogenesis remains unclear. Recently, haplo-identical HCT with post-transplant cyclophosphamide (Haplo-HCT with PTCY) was found to achieve a low incidence rate of acute GVHD and chronic GVHD. However, while the pathogenesis of acute GVHD following Haplo-HCT with PTCY has been well investigated, that of chronic GVHD remains to be elucidated, especially in HLA-matched HCT with PTCY. Based on its safety profile, PTCY is currently applied for the human leucocyte antigen (HLA)-matched HCT setting. Here, we investigated the mechanisms of chronic GVHD following HLA-matched HCT with PTCY using a well-defined mouse chronic GVHD model. PTCY attenuated clinical and pathological chronic GVHD by suppressing effector T-cells and preserving regulatory T-cells compared with a control group. Additionally, we demonstrated that cyclosporine A (CsA) did not show any additional positive effects on attenuation of GVHD in PTCY-treated recipients. These results suggest that monotherapy with PTCY without CsA could be a promising strategy for the prevention of chronic GVHD following HLA-matched HCT., Competing Interests: No potential conflict of interest relevant to this article was reported.

Published
2024
Full Text
View/download PDF

26. Gastrointestinal hemorrhage caused by the direct invasion of a hepatocellular carcinoma successfully treated with polyglycolic acid sheet shielding.

Author

Mannami T, Fujiwara N, Ikeda G, Mishima T, Kuroi T, Muraoka T, and Ohtawa Y

Subjects
Aged, Fatal Outcome, Gastrointestinal Hemorrhage diagnostic imaging, Humans, Male, Tomography, X-Ray Computed, Carcinoma, Hepatocellular complications, Endoscopy, Digestive System, Fibrin Tissue Adhesive therapeutic use, Gastrointestinal Hemorrhage drug therapy, Gastrointestinal Hemorrhage etiology, Liver Neoplasms complications, Polyglycolic Acid therapeutic use
Abstract

Competing Interests: None, (© Georg Thieme Verlag KG Stuttgart · New York.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results